Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest announcement is out from Oxford BioMedica ( (GB:OXB) ).
Oxford BioMedica has appointed Jefferies International Limited as a Joint Corporate Broker and Joint Financial Adviser alongside RBC Capital Markets. This strategic move is expected to bolster OXB’s financial advisory capabilities, potentially enhancing its market operations and industry positioning.
More about Oxford BioMedica
OXB (Oxford BioMedica) is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. With over 25 years of expertise in viral vectors, the company collaborates with leading pharmaceutical and biotechnology firms to enable the delivery of life-changing therapies globally. OXB offers advanced technologies for viral vector manufacturing and has facilities across the UK, France, and the US.
YTD Price Performance: -2.46%
Average Trading Volume: 3,493
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $535.7M
For detailed information about OXB stock, go to TipRanks’ Stock Analysis page.
